NF-kappa B is required for the development of tumor spheroids

Journal of Cellular Biochemistry

Volumn 108, Issue 1, 2009, Pages 169-180

  Gallardo Perez J C ^a   Espinosa, M ^b   Ceballos Cancino, G ^b   Daniel, A ^a   Rodriguez Enriquez S ^c   Aviles, A ^a   Moreno Sanchez R ^c   Melendez Zajgla, J ^b   Maldonado, V ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Cancer; Drug resistance; NF kappa B; Three dimensional cell culture; Transduction pathways; X linked inhibitor of apoptosis proteins

Indexed keywords

CISPLATIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PACLITAXEL; SMALL INTERFERING RNA; STAUROSPORINE; TAMOXIFEN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPHEROID CELL;

APOPTOSIS; CELL LINE, TUMOR; HELA CELLS; HUMANS; NEOPLASMS; NF-KAPPA B; SPHEROIDS, CELLULAR; TRANSFECTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

INTRACISTERNAL A-PARTICLES;

EID: 69249120868     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22237     Document Type: Article

References (51)

1. Arellano-Llamas A, Garcia FJ, Perez D, Cantu D, Espinosa M, De la Garza JG, Maldonado V, Melendez-Zajgla J. 2006. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. BMC Cancer 6:256.
2. Baker FL, Spitzer G, Ajani JA, Brock WA, Lukeman J, Pathak S, Tomasovic B, Thielvoldt D, Williams M, Vines C, Tofilon P. 1986. Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium. Cancer Res 46:1263-1274.
3. Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J. 2001. Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 62:13-19.
4. Barbone D, Yang TM, Morgan JR, Gaudino G, Broaddus VC. 2008. Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem 283:13021-13030.
5. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Gorlach A. 2007. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27:755-761.
6. Burkowski FJ. 1977. A computer simulation of the growth of a tumour in vitro. Comput Programs Biomed 7:203-210.
7. Cilloni D, Messa F, Arruga F, Defilippi I, Morotti A, Messa E, Carturan S, Giugliano E, Pautasso M, Bracco E, Rosso V, Sen A, Martinelli G, Baccarani M, Saglio G. 2006. The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance. Leukemia 20:61-67.
8. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, Taylor CT. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 103:18154-18159.
9. Cummins EP, Comerford KM, Scholz C, Bruning U, Taylor CT. 2007. Hypoxic regulation of NF-kappaB signaling. Methods Enzymol 435:479-492.
10. Deakin AS. 1975. Model for the growth of a solid in vitro tumor. Growth 39:159-165.
11. Dertinger H, Hulser D. 1981. Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction. Radiat Environ Biophys 19:101-107.
12. Devroe E, Silver PA. 2004. Therapeutic potential of retroviral RNAi vectors. Expert Opin Biol Ther 4:319-327.
13. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM, Robine S, Karin M, Kagnoff MF. 2004. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 101:2452-2457.
14. Frankel A, Man S, Elliott P, Adams J, Kerbel RS. 2000. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res 6:3719-3728.
15. Freyer JP. 1998. Decreased mitochondrial function in quiescent cells isolated from multicellular tumor spheroids. J Cell Physiol 176:138-149.
16. Gronvik C, Capala J, Carlsson J. 1996. The non-variation in radiosensitivity of different proliferative states of human glioma cells. Anticancer Res 16:25-31.
17. Jack GD, Cabrera MC, Manning ML, Slaughter SM, Potts M, Helm RF. 2007. Activated stress response pathways within multicellular aggregates utilize an autocrine component. Cell Signal 19:772-781.
18. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH. 2007. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 67:3094-3105.
19. Karin M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436.
20. Khaitan D, Chandna S, Arya MB, Dwarakanath BS. 2006. Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med 4:12.
21. Kolchinsky A, Roninson IB. 1997. Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Res 17:3321-3327.
22. Kunz-Schughart LA. 1999. Multicellular tumor spheroids: Intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23:157-161.
23. Lord EM, Nardella G. 1980. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice. Transplantation 29:119-124.
24. MacDonald HR, Howell RL. 1978. The multicellular spheroid as a model tumor allograft. I. Quantitative assessment of spheroid destruction in alloimmune mice. Transplantation 25:136-140.
25. MacDonald HR, Howell RL, McFarlane DL. 1978. The multicellular spheroid as a model tumor allograft. II. Characterization of spheroid-infiltrating cytotoxic cells. Transplantation 25:141-145.
26. Mekhail TM, Markman M. 2002. Paclitaxel in cancer therapy. Expert Opin Pharmacother 3:755-766.
27. Mueller-Klieser W. 1987. Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 113:101-122.
28. Mueller-Klieser W. 1997. Three-dimensional cell cultures: From molecular mechanisms to clinical applications. Am J Physiol 273:C1109-C1123.
29. Nachmias B, Ashhab Y, Ben-Yehuda D. 2004. The inhibitor of apoptosis protein family (IAPs): An emerging therapeutic target in cancer. Semin Cancer Biol 14:231-243.
30. Ng CE, Keng PC, Sutherland RM. 1986. Density distributions of human squamous carcinoma cells: Influence of growth conditions, proliferative status and DNA content. Int J Cancer 38:413-418.
31. Notarbartolo M, Cervello M, Giannitrapani L, Meli M, Poma P, Dusonchet L, Montalto G, D'Alessandro N. 2004. Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells. Ann N Y Acad Sci 1028:289-293.
32. Okamoto T, Sanda T, Asamitsu K. 2007. NF-kappa B signaling and carcinogenesis. Curr Pharm Des 13:447-462.
33. Olive PL, Durand RE. 1994. Drug and radiation resistance in spheroids: Cell contact and kinetics. Cancer Metastasis Rev 13:121-138.
34. Oloumi A, MacPhail SH, Johnston PJ, Banath JP, Olive PL. 2000. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer Res 60:5747-5753.
35. Philchenkov A. 2004. Caspases: Potential targets for regulating cell death. J Cell Mol Med 8:432-444.
36. Piva R, Belardo G, Santoro MG. 2006. NF-kappaB: A stress-regulated switch for cell survival. Antioxid Redox Signal 8:478-486.
37. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, KarinM. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811.
38. Rodriguez-Enriquez S, Gallardo-Perez JC, Aviles-Salas A, Marin-Hernandez A, Carreno-Fuentes L, Maldonado-Lagunas V, Moreno-Sanchez R. 2008. Energy metabolism transition in multi-cellular human tumor spheroids. J Cell Physiol 216:189-197.
39. Sauer H, Ritgen J, Hescheler J, Wartenberg M. 1998. Hypotonic Ca2+ signaling and volume regulation in proliferating and quiescent cells from multicellular spheroids. J Cell Physiol 175:129-140.
40. Shweiki D, Neeman M, Itin A, Keshet E. 1995. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 92:768-772.
41. St Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM, Kerbel RS. 1996. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat Med 2:1204-1210.
42. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. 1998. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 188:211-216.
43. Sudheerkumar P, Shiras A, Das G, Jagtap JC, Prasad V, Shastry P. 2008. Independent activation of Akt and NF-kappaB pathways and their role in resistance to TNF-alpha mediated cytotoxicity in gliomas. Mol Carcinog 47:126-136.
44. Sutherland RM. 1988. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240:177-184.
45. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. 1996. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93:4974-4978.
46. Walker J, Martin C, Callaghan R. 2004. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy. Eur J Cancer 40:594-605.
47. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. 1998. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
48. Xing H, Wang S, Weng D, Chen G, Yang X, Zhou J, Xu G, Lu Y, Ma D. 2007. Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids. Oncol Rep 17:117-122.
49. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H, Matsumoto K. 1999. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18:179-187.
50. Yuhas JM, Li AP, Martinez AO, Ladman AJ. 1977. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res 37:3639-3643.
51. Zhivotovsky B, Orrenius S. 2006. Carcinogenesis and apoptosis: Paradigms and paradoxes. Carcinogenesis 27:1939-1945.